Genitourinary Malignancies in the Time of COVID-19

December 8, 2020

The COVID-19 pandemic has precipitated many changes in medical practice. View this symposium, where the Fox Chase Cancer Center genitourinary (GU) oncology team will discuss the impact of the pandemic on GU cancer care as well as the latest advances and treatments for GU malignancies.


Adjuvant vs Salvage Radiation Therapy for Prostate Cancer: New Data

Dr. Jessica Karen Wong presents a discussion on Adjuvant vs Salvage Radiation Therapy for Prostate Cancer: New Data.
Jessica Wong, MD, MEng

Jessica Wong, MD, MEng

Assistant Director, Radiation Oncology Residency and Fellowship Training Program

Cancer and COVID-19: A War on Two Fronts

Dr. Kutikov presents Cancer and COVID-19: A War on Two Fronts.

Update on Metastatic Prostate Cancer

Dr. Anari presents updates on Metastatic Prostate Cancer.
Fern Anari, MD

Fern Anari, MD

Assistant Professor, Department of Hematology/Oncology

Update on Metastatic Renal Cell Carcinoma

Dr. Zibelman discusses updates on metastatic renal cell carcinoma.
Matthew Zibelman, MD

Matthew Zibelman, MD

Assistant Professor, Department of Hematology/Oncology

Update on Metastatic Urothelial Carcinoma

Dr. Ghatalia discusses updates on Metastatic Urothelial Carcinoma.
Pooja Ghatalia, MD

Pooja Ghatalia, MD

Assistant Professor, Department of Hematology/Oncology

Updates on Surgery for Bladder, Kidney and Prostate Cancer during COVID-19

Dr. Viterbo presents updates on Surgery for Bladder, Kidney and Prostate Cancer during COVID-19.
Rosalia Viterbo, MD, FACS

Rosalia Viterbo, MD, FACS

Associate Professor, Department of Surgical Oncology